Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

ClinicalTrials.gov ID: NCT06958211

Public ClinicalTrials.gov record NCT06958211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 6:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa.

Study identification

NCT ID
NCT06958211
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
573 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2025
Primary completion
Oct 8, 2026
Completion
Jul 10, 2027
Last update posted
Jul 7, 2026

2025 – 2027

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
60
Facility City State ZIP Site status
Investigative Site US257 Birmingham Alabama 35203
Investigative Site US218 Birmingham Alabama 35244
Investigative Site US239 Montgomery Alabama 36117
Investigative Site US215 Phoenix Arizona 85006
Investigative Site US261 Phoenix Arizona 85037
Investigative Site US240 Tucson Arizona 85718
Investigative Site US262 Encino California 91436
Investigative Site US222 Fountain Valley California 92708
Investigative Site US211 Los Angeles California 90045
Investigative Site US237 Los Angeles California 90056
Investigative Site US234 Northridge California 91325
Investigative Site US250 Santa Ana California 92706
Investigative Site US244 Castle Rock Colorado 80109
Investigative Site US252 Cromwell Connecticut 06416
Investigative Site US208 Boca Raton Florida 33486
Investigative Site US203 Hialeah Florida 33012-3618
Investigative Site US258 Jacksonville Florida 32216
Investigative Site US206 Maitland Florida 32751
Investigative Site US223 Miami Florida 33136
Investigative Site US241 Miami Florida 33147
Investigative Site US202 Miami Florida 33173
Investigative Site US214 Tampa Florida 33609
Investigative Site US247 Tampa Florida 33612
Investigative Site US231 Columbus Georgia 31904
Investigative Site US225 Sandy Springs Georgia 30328
Investigative Site US207 Skokie Illinois 60077
Investigative Site US205 Plainfield Indiana 46168
Investigative Site US264 Lake Charles Louisiana 70601
Investigative Site US266 New Orleans Louisiana 70115
Investigative Site US254 Gambrills Maryland 21054
Investigative Site US201 Marriottsville Maryland 21104
Investigative Site US253 Milford Massachusetts 01757
Investigative Site US227 Needham Massachusetts 02492
Investigative Site US268 Worcester Massachusetts 01605
Investigative Site US238 Ann Arbor Michigan 48103
Investigative Site US230 Auburn Hills Michigan 48326
Investigative Site US251 St Louis Missouri 63110-1010
Investigative Site US271 Wildwood Missouri 63040
Investigative Site US212 Missoula Montana 59804
Investigative Site US216 Las Vegas Nevada 89145
Investigative Site US235 Hoboken New Jersey 07030
Investigative Site US217 Albuquerque New Mexico 87102
Investigative Site US219 Brooklyn New York 11203
Investigative Site US246 Elmhurst New York 11373
Investigative Site US269 Fairport New York 14450
Investigative Site US213 Kew Gardens New York 11415
Investigative Site US242 New York New York 10075
Investigative Site US245 Rochester New York 14620
Investigative Site US259 Huntersville North Carolina 28078
Investigative Site US263 Winston-Salem North Carolina 27104
Investigative Site US228 Cleveland Ohio 44124
Investigative Site US243 Columbus Ohio 43213
Investigative Site US249 Columbus Ohio 43213
Investigative Site US204 Portland Oregon 97201
Investigative Site US226 Plymouth Meeting Pennsylvania 19462
Investigative Site US256 Bluffton South Carolina 29910
Investigative Site US267 Mt. Pleasant South Carolina 29464
Investigative Site US255 Austin Texas 78759
Investigative Site US260 Cypress Texas 77429
Investigative Site US270 Prosper Texas 75078
Investigative Site US232 Sugar Land Texas 77479
Investigative Site US248 Arlington Virginia 22206
Investigative Site US209 Danville Virginia 24541
Investigative Site US229 Norfolk Virginia 23502
Investigative Site US265 Seattle Washington 98105
Investigative Site US224 Spokane Washington 99202
Investigative Site US210 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06958211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06958211 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →